Sintilimab, Cetuximab, Regorafenib,Combine,mCRC
1 clinical trials · Condition
◉ Watch Sintilimab, Cetuximab, Regorafenib,Combine,mCRC
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Sintilimab Combined With Regorafenib and Cetuximab / Sintilimab Combined With Regorafenib in Posterior Line Therapy of Advanced Colorectal Cancer (Regosinti) (NCT04745130) | Tianjin Medical University Cancer Institute and Hospital | 2021-03-01 |
Track Sintilimab, Cetuximab, Regorafenib,Combine,mCRC automatically
Every clearance here is in the API, with alerts when new ones post.